Clinical Trial Update: Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant FOLFOX chemotherapy with short-course radiation and active surveillance for locally advanced rectal cancer; results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: University of Rochester | Conditions: Advanced Rectal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-09-11